Jagdeesh Ullal

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Comparison of Computer-Guided Versus Standard Insulin Infusion Regimens in Patients With Diabetic Ketoacidosis

Jagdeesh Ullal, Joseph Aloi, David Reyes-Umpierrez et al. · Journal of Diabetes Science and Technology · 2018 · 46 citations · Full text

Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting

Joseph Aloi, Bruce W. Bode, Jagdeesh Ullal et al. · Journal of Diabetes Science and Technology · 2016 · 35 citations · Full text

Use of a Computer-Based Insulin Infusion Algorithm to Treat Diabetic Ketoacidosis in the Emergency Department

Jagdeesh Ullal, Raymie McFarland, Margaret Bachand et al. · Diabetes Technology & Therapeutics · 2016 · 22 citations